Home
Home

Gaucher disease

Sanofi's Orphan Drug Eliglustat Tartrate Successful in 2 Late-Stage Trials

Sanofi's Orphan Drug Eliglustat Tartrate Successful in 2 Late-Stage Trials
Motley Fool

Protalix extends collaboration on Gaucher disease drug; Pfizer will manage new Elelyso trials

Protalix extends collaboration on Gaucher disease drug; Pfizer will manage new Elelyso trials
Yahoo/AP

A Home Run Drug in the Holy Land

A Home Run Drug in the Holy Land
Motley Fool

Protalix receives marketing authorization for Elelyso from Israel

Protalix receives marketing authorization for Elelyso from Israel
Yahoo/Fly on the Wall

Gaucher Disease: The Fight For Market Share

Gaucher Disease: The Fight For Market Share
Seeking Alpha

Why Protalix BioTherapeutics Plunged

Why Protalix BioTherapeutics Plunged
Motley Fool

Protalix Receives a $25 Million Milestone Payment for U.S. Approval of ELELYSO(TM)

Protalix Receives a $25 Million Milestone Payment for U.S. Approval of ELELYSO(TM)
Yahoo

Pfizer Should Rise On New Gaucher Drug, Due Out In 2013

Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha

U.S. FDA approves Pfizer/Protalix drug for Gaucher

U.S. FDA approves Pfizer/Protalix drug for Gaucher
Reuters

Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date

Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha